Related Experiment Video
Updated: May 13, 2026
09:36
Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays
Published on: August 13, 2017
Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration
Sreeganga Chandra1, Gilbert Gallardo, Rafael Fernández-Chacón
1Center for Basic Neuroscience, Department of Molecular Genetics, Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Cell
|November 5, 2005
Summary
Alpha-synuclein protects against neurodegeneration caused by CSPalpha deficiency in mice. It acts downstream by binding phospholipids, not by substituting for CSPalpha, revealing a novel protective role.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Alpha-synuclein is implicated in Parkinson's disease, but its normal function is unclear.
- Cysteine-string protein-alpha (CSPalpha) is crucial for neuronal survival, and its absence causes neurodegeneration.
- Both proteins are abundant synaptic vesicle components.
Purpose of the Study:
- To investigate the physiological role of alpha-synuclein in neurodegeneration.
- To determine the relationship between alpha-synuclein and CSPalpha in neuronal protection.
- To elucidate the mechanism by which alpha-synuclein influences CSPalpha-related neurodegeneration.
Main Methods:
- Generated transgenic mice expressing alpha-synuclein.
- Created and analyzed mice with CSPalpha deletion.
- Assessed neurodegeneration phenotypes and SNARE complex assembly.
Main Results:
- Transgenic alpha-synuclein expression rescued lethality and neurodegeneration in CSPalpha-deficient mice.
- Ablation of endogenous synucleins worsened CSPalpha-deficiency phenotypes.
- Alpha-synuclein ameliorated CSPalpha deletion-induced inhibition of SNARE complex assembly.
- Alpha-synuclein's protective effect required phospholipid binding.
Conclusions:
- Alpha-synuclein possesses a potent in vivo neuroprotective activity against nerve terminal injury.
- This activity is independent of substituting for CSPalpha but acts downstream via phospholipid binding.
- Alpha-synuclein functions with CSPalpha and SNARE proteins at the presynaptic membrane.
Related Concept Videos
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...